Formulation: A solid
Formal Name: 5S-(difluoromethyl)-2-(ethylamino)-3aR,6S,7R,7aR-tetrahydro-5H-pyrano[3,2-d]thiazole-6,7-diol
Purity: ≥95%
Formula Markup: C9H14F2N2O3S
CAS Number: 1382799-40-7
Notes: MK-8719 is an inhibitor of O-GlcNAcase (OGA; Ki = 7.9 nM for the human enzyme).{54898} It is selective for OGA over β-hexosaminidase (Ki = >10,000 nM for the human enzyme). MK-8719 increases the levels of O-GlcNAcylated proteins in rat PC12 adrenal medulla cells (EC50 = 52.7 nM). It increases brain levels of O-GlcNAcylated proteins in rats when administered at a dose of 10 mg/kg. Dietary administration of MK-8719 reduces the levels of aggregated tau proteins in the brain, the levels of neurofibril tangles in the entorhinal cortex, and spontaneous locomotor activity, as well as increases cortex, hippocampal, and lateral ventricular volume and forebrain weight, in an rTg4510 transgenic mouse model of Alzheimer's disease.{72402}
English
Deutsch
